Trivedi PJ, Homer V, Hov JR, Trauner M, Quraishi MN, Mullish BH, Hirschfield GM, Cristoferi L, Carbone M(2026) Letter to the Editor Am J Gastroenterol(in press) DOI 10.14309/ajg.0000000000004201, PubMed 42861494
Rønneberg JD, Chung BK, Jiang X, Elias JE, Karlsen TH, Kaneider NC, Hov JR, Schneditz G(2026) GPR35-positive mast cells are enriched in primary sclerosing cholangitis and show an enhanced secretory phenotype Scand J Gastroenterol, 1-11(in press) DOI 10.1080/00365521.2026.2731959, PubMed 42765450
Molinaro A, Braadland PR, Carpino G, Carreras A, Nikolaidis M, Hanzely P, Beck KR, Ali AH, Bossen L, Frank A, Lundqvist A, Juran BD, Overi D, Geng L, Amundsen-Isaksen E, Reims HM, Björk I, Grzyb K, Abildgaard A, Folseraas T, Cornillet M, Helgadóttir H, McCauley BM, Cristoferi L, Carbone M, Cardinale V, Høivik ML, Engesæter LK, Tjønnfjord SKV, McCann Aet al.(2026) Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling Nat Metab, 8(9), 1910-1925 DOI 10.1038/s42255-026-01600-1, PubMed 42698000
